Berk Tas, SentiAR CEO
Medical augmented reality startup SentiAR just closed an $8.5 million Series B round led by cultivate (MD) Ventures and joined by MedVenture Partners alongside TechWald Holding, VCapital, QRM Capital, and Harmonix Fund.
“This funding allows us to… scale up clinical deployments, ” SentiAR CEO Berk Tas said in a statement. Tas did not respond to texts or voicemail requests in time for this article.
The company’s system presents a 3D holographic image of the patient’s heart, showing the real-time positions of catheters used for the procedure via a surgeon-wearable headset.
“3D imaging, and superior visualization, leads to improved efficiencies and downstream efficacy of cardiac ablation outcomes — long term,” Cultivation Capital Managing Partner Bill Schmidt told bizblip.
In 2018 the startup landed Phase I and Phase II SBIR grants from the National Institutes of Health, Department of Health and Human Services totaling $2,221,372 for the commercialization of technologies developed at Washington University, St. Louis by Dr. Jennifer Silva MD and Dr. Jonathan Silva Ph.D. The company has a dozen(ish) full time employees.
The St. Louis-based startup has raised a total of $24.1 million including this round and a $5.1M Series A in April, 2021 and a $500,000 Series Unknown from St. Louis Arch Angels in July, 2021. Existing investors include BioGenerator, Cultivation Capital, Neue Fund, Vcapital, Keiretsu Forum.
